7-day institutional quarantine for international travellers from 'at-risk' nations in Maharashtra
Mumbai/IBNS: The Maharashtra government on Tuesday announced that all international passengers arriving from "at-risk" countries will have to undergo a mandatory seven-day institutional quarantine and take RT-PCR tests for COVID-19 thrice - on the second, fourth, and seventh days after arrival, reports said.
Travellers who test positive will be shifted to a hospital.
Even those testing negative will have to undergo an additional seven days of home quarantine, the government order said.
The state government adopted these measures after the Centre announced travel guidelines on Nov 28 in view of 'Omicron' strain.
The new strain of Covid has been designated a variant of concern.
Existing COVID-19 tests like RT-PCR and RAT can detect traces of Omicon variant, Health Minister Mansukh Mandaviya told the Parliament earlier in the day.
Omicron is also traceable from the faster antigen tests, Health Secretary Rajesh Bhushan told states and UTs on Tuesday, urging them to scale up testing for early identification and management of cases.
The Union Health Secretary advised states to not to let their guards down and keep a strict vigil on the international passengers coming to the country through various airports, ports and land border crossings.
The states were specially advised to test samples of international travelers coming from "at risk" countries on the first day and retest them on the 8th day.
International passengers from “at risk” countries are being advised to prepare to wait at the airports till the report of the RT-PCR test has come, and not book connecting flights beforehand.
The states have been directed to send all positive samples for genome sequencing to INSACOG Labs (mapped with states) promptly.
They are also required to undertake contact tracing of positive individuals and follow up for 14 days.
Meanwhile, raising the alarm, vaccine manufacturer Moderna chief has warned that the currently operating jabs might be less effective against the Omicron strain, which was first believed to be detected in South Africa.
Stéphane Bancel told Financial Times the high number of Omicron mutations on the spike protein, which the virus uses to infect human cells, and the rapid spread of the variant in South Africa suggested that the current crop of vaccines may need to be modified next year.
“There is no world, I think, where [the effectiveness] is the same level . . . we had with [the] Delta [variant],” Bancel told the Financial Times in an interview at the company’s headquarters in Cambridge, Massachusetts.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.